|Nathalie Y. R. Agar, PhD||Clare M. Tempany, MD||Alexandra Golby, MD||Stephan E. Maier, MD, PhD|
|Junichi Tokuda, PhD||Fiona M. Fennessy, MD, PhD||Sandro Santagata, MD, PhD||Filip Szczepankiewicz, PhD|
Led by Nathalie Agar, the focus areas for the Imaging Cancer Heterogeneity TRD are:
Integrating mass spectrometry imaging (MSI) of tissue metabolism, MRI, and histopathology for the assessment of brain tumor heterogeneity.
New diffusion imaging sequences to characterize cell architecture traits in prostate cancer.
New MRI pulse sequence for blood oxygenation mapping that accelerates acquisition speed more than ten-fold, without sacrificing volume coverage.